C168H188N26O13 — CID 162137515
2-[4-(adamantane-1-carbonylamino)phenyl]-N-(3-tert-butyl-1-methylpyrazol-5-yl)-3H-benzimidazole-5-carboxamide;2-[4-(adamantane-1-carbonylamino)phenyl]-N-(2-phenylmethoxycyclopentyl)-3H-benzimidazole-5-carboxamide;2-[4-[(3-tert-butyl-1-methylpyrazole-5-carbonyl)amino]phenyl]-N-(3-tert-butyl-1-methylpyrazol-5-yl)-3H-benzimidazole-5-carboxamide;2-[4-(cycloheptanecarbonylamino)phenyl]-N-(2-phenylmethoxycyclopentyl)-3H-benzimidazole-5-carboxamide;2-[4-(cyclohexanecarbonylamino)phenyl]-N-(2-phenylmethoxycyclopentyl)-3H-benzimidazole-5-carboxamide (PubChem CID 162137515) has the molecular formula C168H188N26O13 and a molecular weight of 2779.52 g/mol. Its IUPAC name is 2-[4-(adamantane-1-carbonylamino)phenyl]-N-(3-tert-butyl-1-methylpyrazol-5-yl)-3H-benzimidazole-5-carboxamide;2-[4-(adamantane-1-carbonylamino)phenyl]-N-(2-phenylmethoxycyclopentyl)-3H-benzimidazole-5-carboxamide;2-[4-[(3-tert-butyl-1-methylpyrazole-5-carbonyl)amino]phenyl]-N-(3-tert-butyl-1-methylpyrazol-5-yl)-3H-benzimidazole-5-carboxamide;2-[4-(cycloheptanecarbonylamino)phenyl]-N-(2-phenylmethoxycyclopentyl)-3H-benzimidazole-5-carboxamide;2-[4-(cyclohexanecarbonylamino)phenyl]-N-(2-phenylmethoxycyclopentyl)-3H-benzimidazole-5-carboxamide.
| Compound Name | 2-[4-(adamantane-1-carbonylamino)phenyl]-N-(3-tert-butyl-1-methylpyrazol-5-yl)-3H-benzimidazole-5-carboxamide;2-[4-(adamantane-1-carbonylamino)phenyl]-N-(2-phenylmethoxycyclopentyl)-3H-benzimidazole-5-carboxamide;2-[4-[(3-tert-butyl-1-methylpyrazole-5-carbonyl)amino]phenyl]-N-(3-tert-butyl-1-methylpyrazol-5-yl)-3H-benzimidazole-5-carboxamide;2-[4-(cycloheptanecarbonylamino)phenyl]-N-(2-phenylmethoxycyclopentyl)-3H-benzimidazole-5-carboxamide;2-[4-(cyclohexanecarbonylamino)phenyl]-N-(2-phenylmethoxycyclopentyl)-3H-benzimidazole-5-carboxamide |
|---|---|
| PubChem CID | 162137515 |
| Molecular Formula | C168H188N26O13 |
| Molecular Weight | 2779.52 g/mol |
| Exact Mass | 2777.48 |
| IUPAC Name | 2-[4-(adamantane-1-carbonylamino)phenyl]-N-(3-tert-butyl-1-methylpyrazol-5-yl)-3H-benzimidazole-5-carboxamide;2-[4-(adamantane-1-carbonylamino)phenyl]-N-(2-phenylmethoxycyclopentyl)-3H-benzimidazole-5-carboxamide;2-[4-[(3-tert-butyl-1-methylpyrazole-5-carbonyl)amino]phenyl]-N-(3-tert-butyl-1-methylpyrazol-5-yl)-3H-benzimidazole-5-carboxamide;2-[4-(cycloheptanecarbonylamino)phenyl]-N-(2-phenylmethoxycyclopentyl)-3H-benzimidazole-5-carboxamide;2-[4-(cyclohexanecarbonylamino)phenyl]-N-(2-phenylmethoxycyclopentyl)-3H-benzimidazole-5-carboxamide |
| SMILES | Cn1nc(C(C)(C)C)cc1NC(=O)c1ccc2nc(-c3ccc(NC(=O)C45CC6CC(CC(C6)C4)C5)cc3)[nH]c2c1.Cn1nc(C(C)(C)C)cc1NC(=O)c1ccc2nc(-c3ccc(NC(=O)c4cc(C(C)(C)C)nn4C)cc3)[nH]c2c1.O=C(NC1CCCC1OCc1ccccc1)c1ccc2nc(-c3ccc(NC(=O)C45CC6CC(CC(C6)C4)C5)cc3)[nH]c2c1.O=C(NC1CCCC1OCc1ccccc1)c1ccc2nc(-c3ccc(NC(=O)C4CCCCC4)cc3)[nH]c2c1.O=C(NC1CCCC1OCc1ccccc1)c1ccc2nc(-c3ccc(NC(=O)C4CCCCCC4)cc3)[nH]c2c1 |
| InChI | InChI=1S/C37H40N4O3.C34H38N4O3.C33H38N6O2.C33H36N4O3.C31H36N8O2/c42-35(41-31-7-4-8-33(31)44-22-23-5-2-1-3-6-23)28-11-14-30-32(18-28)40-34(39-30)27-9-12-29(13-10-27)38-36(43)37-19-24-15-25(20-37)17-26(16-24)21-37;39-33(25-11-6-1-2-7-12-25)35-27-18-15-24(16-19-27)32-36-28-20-17-26(21-30(28)37-32)34(40)38-29-13-8-14-31(29)41-22-23-9-4-3-5-10-23;1-32(2,3)27-15-28(39(4)38-27)37-30(40)23-7-10-25-26(14-23)36-29(35-25)22-5-8-24(9-6-22)34-31(41)33-16-19-11-20(17-33)13-21(12-19)18-33;38-32(24-10-5-2-6-11-24)34-26-17-14-23(15-18-26)31-35-27-19-16-25(20-29(27)36-31)33(39)37-28-12-7-13-30(28)40-21-22-8-3-1-4-9-22;1-30(2,3)24-16-23(38(7)36-24)29(41)32-20-12-9-18(10-13-20)27-33-21-14-11-19(15-22(21)34-27)28(40)35-26-17-25(31(4,5)6)37-39(26)8/h1-3,5-6,9-14,18,24-26,31,33H,4,7-8,15-17,19-22H2,(H,38,43)(H,39,40)(H,41,42);3-5,9-10,15-21,25,29,31H,1-2,6-8,11-14,22H2,(H,35,39)(H,36,37)(H,38,40);5-10,14-15,19-21H,11-13,16-18H2,1-4H3,(H,34,41)(H,35,36)(H,37,40);1,3-4,8-9,14-20,24,28,30H,2,5-7,10-13,21H2,(H,34,38)(H,35,36)(H,37,39);9-17H,1-8H3,(H,32,41)(H,33,34)(H,35,40) |
| InChIKey | ZJMHCOSHPJZMLJ-UHFFFAOYSA-N |
| XLogP | 33.34 |
| TPSA | 515.55 Ų |
| H-Bond Donors | 15 |
| H-Bond Acceptors | 24 |
| Rotatable Bonds | 34 |
| Heavy Atoms | 207 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2779.52 |
| LogP ≤ 5 | 33.34 |
| H-Bond Donors ≤ 5 | 15 |
| H-Bond Acceptors ≤ 10 | 24 |